10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2011 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2011 10-K (Filed: Feb 17, 2012) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | |
| Net revenues | $ 107,100 | 95,778 | 98,215 |
| Cost of revenues | 86,539 | 75,559 | 77,857 |
| Gross profit | 20,561 | 20,219 | 20,358 |
| Operating expenses | 14,231 | 14,082 | 13,933 |
| Operating profit | 6,330 | 6,137 | 6,425 |
| Interest expense, net | 584 | 536 | 525 |
| Income before income tax provision | 5,746 | 5,601 | 5,900 |
| Income tax provision | 2,258 | 2,179 | 2,200 |
| Income from continuing operations | 3,488 | 3,422 | 3,700 |
| Income (loss) from discontinued operations, net of tax | (31) | 2 | (4) |
| Net income | 3,457 | 3,424 | 3,696 |
| Net loss attributable to noncontrolling interest | 4 | 3 | |
| Net income attributable to CVS Caremark | 3,461 | 3,427 | 3,696 |
| Basic earnings per common share: | |||
| Income from continuing operations attributable to CVS Caremark (in dollars per share) | 2.61 | 2.51 | 2.58 |
| Loss from discontinued operations attributable to CVS Caremark (in dollars per share) | (0.02) | ||
| Net income attributable to CVS Caremark (in dollars per share) | 2.59 | 2.51 | 2.58 |
| Weighted average common shares outstanding (in shares) | 1,338 | 1,367 | 1,434 |
| Diluted earnings per common share: | |||
| Income from continuing operations attributable to CVS Caremark (in dollars per share) | 2.59 | 2.49 | 2.55 |
| Loss from discontinued operations attributable to CVS Caremark (in dollars per share) | (0.02) | ||
| Net income attributable to CVS Caremark (in dollars per share) | 2.57 | 2.49 | 2.55 |
| Weighted average common shares outstanding (in shares) | 1,347 | 1,377 | 1,450 |
| Dividends declared per common share (in dollars per share) | 0.50 | 0.35 | 0.30 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2011 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2011 10-K (Filed: Feb 17, 2012) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | |
| Cash flows from operating activities: | |||
| Cash receipts from customers | $ 97,688 | 94,503 | 93,568 |
| Cash paid for inventory and prescriptions dispensed by retail network pharmacies | (75,148) | (73,143) | (73,536) |
| Cash paid to other suppliers and employees | (13,635) | (13,778) | (13,121) |
| Interest received | 4 | 4 | 5 |
| Interest paid | (647) | (583) | (542) |
| Income taxes paid | (2,406) | (2,224) | (2,339) |
| Net cash provided by operating activities | 5,856 | 4,779 | 4,035 |
| Cash flows from investing activities: | |||
| Purchases of property and equipment | (1,872) | (2,005) | (2,548) |
| Proceeds from sale-leaseback transactions | 592 | 507 | 1,562 |
| Proceeds from sale of property and equipment | 4 | 34 | 23 |
| Acquisitions (net of cash acquired) and other investments | (1,441) | (177) | (101) |
| Purchase of available-for-sale investments | (3) | (5) | |
| Sale or maturity of available-for-sale investments | 60 | 1 | |
| Proceeds from sale of subsidiary | 250 | ||
| Net cash used in investing activities | (2,410) | (1,640) | (1,069) |
| Cash flows from financing activities: | |||
| Increase (decrease) in short-term debt | 450 | (15) | (2,729) |
| Proceeds from issuance of long-term debt | 1,463 | 991 | 2,800 |
| Repayments of long-term debt | (2,122) | (2,103) | (653) |
| Dividends paid | (674) | (479) | (439) |
| Derivative settlements | (19) | (5) | (3) |
| Proceeds from exercise of stock options | 431 | 285 | 250 |
| Excess tax benefits from stock-based compensation | 21 | 28 | 19 |
| Repurchase of common stock | (3,001) | (1,500) | (2,477) |
| Other | (9) | ||
| Net cash used in financing activities | (3,460) | (2,798) | (3,232) |
| Net increase (decrease) in cash and cash equivalents | (14) | 341 | (266) |
| Cash and cash equivalents at the beginning of the year | 1,427 | 1,086 | |
| Cash and cash equivalents at the end of the year | 1,413 | 1,427 | 1,086 |
| Reconciliation of net income to net cash provided by operating activities: | |||
| Net income | 3,457 | 3,424 | 3,696 |
| Adjustments required to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 1,568 | 1,469 | 1,389 |
| Stock-based compensation | 135 | 150 | 165 |
| Gain on sale of subsidiary | (53) | ||
| Deferred income taxes and other noncash items | 144 | 30 | 48 |
| Change in operating assets and liabilities, net of effects from acquisitions: | |||
| Accounts receivable, net | (748) | 532 | (86) |
| Inventories | 607 | (352) | (1,199) |
| Other current assets | (420) | (4) | 48 |
| Other assets | (49) | (210) | (2) |
| Accounts payable | 1,128 | (40) | 4 |
| Accrued expenses | 85 | (176) | (66) |
| Other long-term liabilities | 2 | (44) | 38 |
| Net cash provided by operating activities | 5,856 | 4,779 | 4,035 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
CVS HEALTH CORP | ||
Ticker: CVS Fiscal Year: 2011 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2011 10-K (Filed: Feb 17, 2012) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2011 | Dec 31, 2010 | |
| Assets: | ||
| Cash and cash equivalents | $ 1,413 | 1,427 |
| Short-term investments | 5 | 4 |
| Accounts receivable, net | 6,047 | 4,925 |
| Inventories | 10,046 | 10,695 |
| Deferred income taxes | 503 | 511 |
| Other current assets | 580 | 144 |
| Total current assets | 18,594 | 17,706 |
| Property and equipment, net | 8,467 | 8,322 |
| Goodwill | 26,458 | 25,669 |
| Intangible assets, net | 9,869 | 9,784 |
| Other assets | 1,155 | 688 |
| Total assets | 64,543 | 62,169 |
| Liabilities: | ||
| Accounts payable | 4,370 | 4,026 |
| Claims and discounts payable | 3,487 | 2,569 |
| Accrued expenses | 3,293 | 3,070 |
| Short-term debt | 750 | 300 |
| Current portion of long-term debt | 56 | 1,105 |
| Total current liabilities | 11,956 | 11,070 |
| Long-term debt | 9,208 | 8,652 |
| Deferred income taxes | 3,853 | 3,655 |
| Other long-term liabilities | 1,445 | 1,058 |
| Commitments and contingencies (Note 13) | ||
| Redeemable noncontrolling interest | 30 | 34 |
| Shareholders' equity: | ||
| Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding | ||
| Common stock, par value $0.01: 3,200 shares authorized; 1,640 shares issued and 1,298 shares outstanding at December 31, 2011 and 1,624 shares issued and 1,363 shares outstanding at December 31, 2010 | 16 | 16 |
| Treasury stock, at cost: 340 shares at December 31, 2011 and 259 shares at December 31, 2010 | (11,953) | (9,030) |
| Shares held in trust: 2 shares at December 31, 2011 and 2010 | (56) | (56) |
| Capital surplus | 28,126 | 27,610 |
| Retained earnings | 22,090 | 19,303 |
| Accumulated other comprehensive loss | (172) | (143) |
| Total shareholders' equity | 38,051 | 37,700 |
| Total liabilities and shareholders' equity | 64,543 | 62,169 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2011 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |